Development of competitive PCR and the QPCR system 5000 as a transcription-based screen

Area of Science:

• Molecular Biology
• Genetics
• Pharmacology

Background:

• Accurate quantification of gene expression is crucial for understanding biological processes and identifying therapeutic targets.
• Existing methods for gene expression analysis can be time-consuming and lack the sensitivity required for high-throughput screening.

Purpose of the Study:

• To develop and validate a simple, reproducible quantitative PCR (QPCR) assay for screening compounds that modulate gene regulation.
• To assess the sensitivity and efficiency of the QPCR System 5000 for competitive PCR applications.

Main Methods:

• Utilized the Perkin-Elmer QPCR System 5000 with competitive PCR to quantify Insulin-like Growth Factor 1 (IGF-1) mRNA.
• Employed sequence-specific probes for distinguishing internal standards from wild-type PCR products.
• Tested assay sensitivity using serial dilutions of rat liver cDNA.

Main Results:

• The QPCR System 5000 accurately distinguished between internal standard and wild-type products.
• The assay detected twofold changes in cDNA amounts, demonstrating high sensitivity.
• The system processed 24 competitive PCR reactions (48 samples) in approximately one hour.

Conclusions:

• The QPCR System 5000 provides a sensitive, automated, and efficient platform for competitive PCR.
• This assay format is suitable for establishing screens to discover compounds affecting gene regulation.
• The system facilitates the measurement of transcriptional regulation for various messenger RNAs (mRNAs).